Keith C. Kummerfeld

Vice President of Finance, Arcturus Therapeutics.

Companies

Arcturus TherapeuticsOfficer Sep 12, 2019 to Dec 19, 2023¹
Arcturus TherapeuticsVice President of Finance Jan 2, 2019 to Feb 11, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Arcturus Therapeutics ARCT950 shares³$9.9K at $10.37Jul 14, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Jul 14, 2023Sold 6,968 shares at $35.00 of Arcturus Therapeutics³
Jul 14, 2023Exercised options 1,031 shares at $14.12 of Arcturus Therapeutics³
Jul 14, 2023Exercised options 1,437 shares at $4.99 of Arcturus Therapeutics³
Jul 14, 2023Exercised options 4,500 shares at $9.04 of Arcturus Therapeutics³
Apr 18, 2023Sold 6,968 shares at $28.18 of Arcturus Therapeutics⁴
Apr 18, 2023Exercised options 1,437 shares at $4.99 of Arcturus Therapeutics⁴
Apr 18, 2023Exercised options 4,500 shares at $9.04 of Arcturus Therapeutics⁴
Apr 18, 2023Exercised options 1,031 shares at $14.12 of Arcturus Therapeutics⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARArcturus Therapeutics, Officer
2
SEC EDGARArcturus Therapeutics, Vice President of Finance
3
SEC EDGARArcturus Therapeutics shares after the filing of Jul 14, 2023
4
SEC EDGARForm 4 filed Apr 19, 2023